Michael Vasile

Michael Vasile has extensive experience in pharmaceutical sales, currently serving as a Senior Hospital Sales Executive at Paratek Pharmaceuticals since August 2019, where Michael has played a critical role in launching and promoting Nuzyra to multidisciplinary medical professionals. Prior to this, Michael worked at UCB from August 2017 to August 2019, focusing on sales for the epilepsy drug Briviact and building market share for Vimpat. Their career began at Allergan from February 2013 to January 2018, where Michael advanced from Sales Representative to Senior Sales Representative, driving launches for products such as Viberzi and Restasis Multidose. Michael holds a Bachelor's degree in Business Administration with a focus on Management and Operations from Hartwick College, obtained in 2006.